3D Diagnostic Imaging plc CFO Appointment

Following last month’s announcement regarding the completion of an exclusive agreement between CarieScan Ltd, 3D’s main operating subsidiary, and Patterson Dental, the largest distributor of dental equipment in North America, for the distribution of the Company’s CarieScan PROtm (“PROtm”) product in the USA, 3D is pleased to announce the strengthening of its Board with immediate effect through the appointment of Oliver Cooke to the post of Chief Finance Officer.

Mr Cooke (55) is a Chartered Accountant and has over 30 years of financial and business development experience gained in a range of quoted and private companies. Mr Cooke also currently holds the post of Executive Chairman of St Helens Capital Partners LLP, a corporate finance boutique and the largest PLUS Market Corporate Advisor by number of clients.

Mr Cooke’s most recent public company role was as Executive Chairman of AIM-listed Multi Group Plc. When he joined the business in 2003 it was heavily loss making and had a market capitalisation of c. £2.5 million. At the time of his departure in 2007 the business has been fully restructured, had moved into a new market sector and its market capitalisation had grown to c. £18.4 million.

Graham Lay, Chief Executive Officer of 3D Diagnostic Imaging said, “We are very pleased that Oliver has accepted this role at this important time for the Company. He brings with him solid financial experience and his knowledge of the Company’s business and long-term strategies is unmatched..”

Oliver Cooke commented, “3D is a young company with terrific growth prospects and I am delighted to be joining a very capable team and look forward to helping them with the delivery of that growth”.

The directors accept responsibility for the content of this announcement.

For further information please contact:

3D Diagnostic Imaging Plc +44 (0) 1382 560 910 Graham Lay, CEO

Fisher Corporate Plc PLUS Corporate Adviser Gary Miller +44 (0) 207 388 7000

St Helens Capital Partners LLP Financial Adviser Mark Anwyl +44 (0) 207 368 6959 Buchanan Communications Financial PR Diane Stewart Carrie Clement +44 (0) 207 466 5000

CarieScan PROtm

The PROtm is a highly accurate, easy to use, hand held device for the early detection and monitoring of dental caries (tooth decay). The PROtm already has CE Mark and FDA 510K approval for sale in Europe and the USA.

The CarieScan PROtm measures the presence of tooth decay earlier and more accurately than any other device on the market and is more than 90% accurate in detecting both sound and carious teeth, well ahead of other methods. It detects “hidden” decay, providing dental practitioners with the opportunity to arrest or even reverse decay, driving the trend towards preventative dental care.

The lightweight caries detection monitor not only offers best-in-class performance for decay detection but also allows easy monitoring of the effect of treatment regimes to show decay advancement or regression, thus enabling dentists to tailor treatment to the needs of the patient at a low cost. The CarieScan PROtm consists of a hand piece and a disposable sensor which is held against the tooth being examined in a process which takes approximately 4 seconds per tooth with the result displayed on the CarieScan PROtm.

MORE ON THIS TOPIC